The Effects of Acyl and Desacyl Forms of The Ghrelin Hormone on The Body

Yıl 2020, Cilt: 2 Sayı: 1, 18 - 27, 30.04.2020

Emine Elibol , Yasemin Akdevelioğlu

Öz

Discovered as the endogenous ligand of the growth hormone secretagogue receptor, the ghrelin hormone is a small 28-amino acid peptide. This hormone is produced by certain tissues of the stomach, the brain, the liver, the kidneys, the pancreas, the pituitary gland, and adipose tissue. Major forms of ghrelin in plasma are acyl and desacyl ghrelin. While decacyl ghrelin was first thought to be an intermediate or degradation product of acyl ghrelin, today it has been found that desacyl ghrelin has metabolic effects on the body as a separate hormone. For this reason, this review was made to evaluate the effects of acyl and desacyl ghrelin on the body. Ghrelin causes a biological effect by binding to the growth hormone secretogogue receptors in the body. Only the acyl ghrelin hormone can bind to the growth hormone secretagogue receptor 1a. Des acyl cannot bind. As a result of studies, it has been determined that acyl ghrelin has an effect on appetite increase, growth hormone release, in addition to body weight and insulin resistance. Desacyl ghrelin has an effect on appetite decreas, body weight, as well as increase in insulin sensitivity. Moreover, it has been emphasized in recent years that desacyl ghrelin may be a strong inhibitor of the acyl ghrelin hormone. However, the effects of these two hormones in some patients are not fully understood. Therefore, studies investigating the effects of these hormones on different diseases should be conducted in the future.

Anahtar Kelimeler

ghrelin, acyl ghrelin, desacyl ghrelin, disease

Kaynakça

• Reference1 Akamizu, T., Iwakura, H., Ariyasu, H., Hosoda, H., Murayama, T., Yokode, M., Teramukai S., Seno H., Chiba T., Noma, S., Nakai Y., Fukunaga M., Nkayi Y., & Kangawa K. (2008). Repeated administration of ghrelin to patients with functional dyspepsia: its effects on food intake and appetite. European Journal of Endocrinology, 158(4), 491-498. Reference2 Allas, S., Caixàs, A., Poitou, C., Coupaye, M., Thuilleaux, D., Lorenzini, F., Diene G., Crino A., Illouz F., Grugni, G., Potvin D., Bocchini S., Delale T., Abribat T., & Tauber M. (2018). AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial. PloS one, 13(1), e0190849. Reference3 Asakawa, A., Inui, A., Fujimiya, M., Sakamaki, R., Shinfuku, N., Ueta, Y., Meguid MM., & Kasuga, M. (2005). Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut, 54(1), 18-24. Reference4 Banks, W. A., Tschöp, M., Robinson, S. M., & Heiman, M. L. (2002). Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. Journal of Pharmacology and Experimental Therapeutics, 302(2), 822-827. Reference5 Barazzoni, R., Bosutti, A., Stebel, M., Cattin, M. R., Roder, E., Visintin, L.,Cattin L., Biolo G., Zannetti., & Guarnieri, G. (2005). Ghrelin regulates mitochondrial-lipid metabolism gene expression and tissue fat distribution in liver and skeletal muscle. American Journal of Physiology-Endocrinology And Metabolism, 288(1), E228-E235. Reference6 Barazzoni, R., Zanetti, M., Ferreira, C., Vinci, P., Pirulli, A., Mucci, M., Dore, F., Fonda, M., Ciocchi, B., Cattin, L., & Guarnieri G. (2007). Relationships between desacylated and acylated ghrelin and insulin sensitivity in the metabolic syndrome. The Journal of Clinical Endocrinology & Metabolism, 92(10), 3935-3940. Reference7 Benso, A., St-Pierre, D., Prodam, F., Gramaglia, E., Granata, R., van der Lely, AJ., Ghigo, E., & Broglio, F. (2012). Metabolic effects of overnight continuous infusion of unacylated ghrelin in humans. European Journal of Endocrinology, 166(5), 911-916. Reference8 Broglio, F., Gottero, C., Prodam, F., Gauna, C., Muccioli, G., Papotti, M., Abribat, T., Van der Lelly, AJ., & Ghigo, E. (2004). Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. The Journal of Clinical Endocrinology & Metabolism, 89(6), 3062-3065. Reference9 Cassoni, P., Allia, E., Marrocco, T., Ghè, C., Ghigo, E., Muccioli, G., & Papotti, M. (2006). Ghrelin and cortistatin in lung cancer: expression of peptides and related receptors in human primary tumors and in vitro effect on the H345 small cell carcinoma cell line. Journal of endocrinological investigation, 29(9), 781-790. Reference10 Cassoni, P., Ghé, C., Marrocco, T., Tarabra, E., Allia, E., Catapano, F., Deghenghi, R., Ghigo, E., Papotti, M., & Muccioli, G. (2004). Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines. European Journal of Endocrinology, 150(2), 173-184. Reference11 Chen, CY., Inui, A., Asakawa, A., Fujino, K., Kato, I., Chen, CC., Ueno, N., & Fujimiya, M. (2005). Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats. Gastroenterology, 129(1), 8-25. Reference12 Choi, K., Roh, S.-G., Hong, Y.-H., Shrestha, Y. B., Hishikawa, D., Chen, C., Kojima, M., Kangawa, K., & Sasaki, S.-I. (2003). The role of ghrelin and growth hormone secretagogues receptor on rat adipogenesis. Endocrinology, 144(3), 754-759. Reference13 Churm, R., Davies, J., Stephens, J., & Prior, S. (2017). Ghrelin function in human obesity and type 2 diabetes: a concise review. Obesity reviews, 18(2), 140-148. Reference14 Conn, M. (Series editor) (2012). Contemporary Endocrinology. Smith, R. G., & Thorner, M. O. (Eds.). (2012). Ghrelin in health and disease (Vol. 10). Springer Science & Business Media. Reference15 Dallak, M. A. (2018). Acylated ghrelin induces but deacylated ghrelin prevents hepatic steatosis and insulin resistance in lean rats: Effects on DAG/PKC/JNK pathway. Biomedicine & Pharmacotherapy, 105, 299-311. Reference16 Delhanty, P., van Koetsveld, P. M., Gauna, C., van de Zande, B., Vitale, G., Hofland, L. J., & van der Lely, A. J. (2007). Ghrelin and its unacylated isoform stimulate the growth of adrenocortical tumor cells via an anti-apoptotic pathway. American Journal of Physiology-Endocrinology And Metabolism, 293(1), E302-E309. Reference17 Delhanty, P. J., Neggers, S. J., & van der Lely, A. J. (2012). Mechanisms in endocrinology: Ghrelin: the differences between acyl- and des-acyl ghrelin. Eur J Endocrinol, 167(5), 601-608. doi:10.1530/EJE-12-0456 Reference18 Delhanty, P. J., Neggers, S. J., & van der Lely, A. J. (2013). Des-acyl ghrelin: a metabolically active peptide. In The Ghrelin System (Vol. 25, pp. 112-121): Karger Publishers. Reference19 Delhanty, P. J., van der Eerden, B. C., & van Leeuwen, J. P. (2014). Ghrelin and bone. Biofactors, 40(1), 41-48. Reference20 DelParigi, A., Tschöp, M., Heiman, M. L., Salbe, A. D., Vozarova, B., Sell, S. M., Bunt, JC., Tataranni, P. A. (2002). High circulating ghrelin: a potential cause for hyperphagia and obesity in Prader-Willi syndrome. The Journal of Clinical Endocrinology & Metabolism, 87(12), 5461-5464. Reference21 Delporte, C. (2013). Structure and physiological actions of ghrelin. Scientifica, 2013,1-25. Reference22 Dezaki, K., Hosoda, H., Kakei, M., Hashiguchi, S., Watanabe, M., Kangawa, K., & Yada, T. (2004). Endogenous ghrelin in pancreatic islets restricts insulin release by attenuating Ca2+ signaling in β-cells: implication in the glycemic control in rodents. Diabetes, 53(12), 3142-3151. Reference23 DiGruccio, MR., Mawla, AM., Donaldson, CJ., Noguchi, GM., Vaughan, J., Cowing-Zitron, C., vav der Meulen, T., & Huising, MO. (2016). Comprehensive alpha, beta and delta cell transcriptomes reveal that ghrelin selectively activates delta cells and promotes somatostatin release from pancreatic islets. Molecular metabolism, 5(7), 449-458. Reference24 Fernández-Fernández, R., Tena-Sempere, M., Aguilar, E., & Pinilla, L. (2004). Ghrelin effects on gonadotropin secretion in male and female rats. Neuroscience letters, 362(2), 103-107. Reference25 Furuta, M., Funabashi, T., & Kimura, F. (2001). Intracerebroventricular administration of ghrelin rapidly suppresses pulsatile luteinizing hormone secretion in ovariectomized rats. Biochemical and biophysical research communications, 288(4), 780-785. Reference26 Giovambattista, A., Gaillard, RC., & Spinedi, E. (2007). Ghrelin gene‐related peptides modulate rat white adiposity. Vitamins & Hormones, 77, 171-205. Reference27 Harvey, R., & Ferrier, D. (2015). Lippincott Illustrated Reviews: Biochemistry. Ankara: Nobel tıp kitapevi. Reference28 Hosoda, H., Kojima, M., & Kangawa, K. (2006). Biological, physiological, and pharmacological aspects of ghrelin. Journal of pharmacological sciences, 100(5), 398-410. Reference29 Hotta, M., Ohwada, R., Katakami, H., Shibasaki, T., Hizuka, N., & Takano, K. (2004). Plasma levels of intact and degraded ghrelin and their responses to glucose infusion in anorexia nervosa. The Journal of Clinical Endocrinology & Metabolism, 89(11), 5707-5712. Reference30 Inhoff, T., Mönnikes, H., Noetzel, S., Stengel, A., Goebel, M., Dinh, Q. T., Rieldl, A., Bannert, N., Wisser, AS., Wiedenmann, B., Klapp, BF., & Kobelt. (2008). Desacyl ghrelin inhibits the orexigenic effect of peripherally injected ghrelin in rats. Peptides, 29(12), 2159-2168. Reference31 Inhoff, T., Wiedenmann, B., Klapp, B. F., Mönnikes, H., & Kobelt, P. (2009). Is desacyl ghrelin a modulator of food intake? Peptides, 30(5), 991-994. Reference32 Iqbal, J., Kurose, Y., Canny, B., & Clarke, I. J. (2006). Effects of central infusion of ghrelin on food intake and plasma levels of growth hormone, luteinizing hormone, prolactin, and cortisol secretion in sheep. Endocrinology, 147(1), 510-519. Reference33 Jiao, Q., Du, X., Li, Y., Gong, B., Shi, L., Tang, T., & Jiang, H. (2017). The neurological effects of ghrelin in brain diseases: Beyond metabolic functions. Neuroscience & Biobehavioral Reviews, 73, 98-111. Reference34 Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., & Kangawa, K. (1999). Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature, 402(6762), 656. Reference35 Kojima, M., & Kangawa, K. (2002). Ghrelin, an orexigenic signaling molecule from the gastrointestinal tract. Current opinion in pharmacology, 2(6), 665-668. Reference36 Kojima, M., & Kangawa, K. (2005). Ghrelin: structure and function. Physiological reviews, 85(2), 495-522. Reference37 Kraus, D., Reckenbeil, J., Wenghoefer, M., Stark, H., Frentzen, M., Allam, JP., Novak, N., Frede, S., Götz, W., Probstmeier, R., Meyer, R., & Winter, J. (2016). Ghrelin promotes oral tumor cell proliferation by modifying GLUT1 expression. Cellular and molecular life sciences, 73(6), 1287-1299. Reference38 Lee, SY., & Cho, YH. (2015). Relationships Between Insulin Resistance, Acyl Ghrelin, Deacyl Ghrelin and Ghrelin O-Acyltransferase in Middle Aged Men. Canadian Journal of Diabetes, 39(6), 535. Reference39 Li, L., Zhang, LK., Pang, YZ., Pan, CS., Qi, YF., Chen, L., Wang,X., Tang, CS., & Zhang, J. (2006). Cardioprotective effects of ghrelin and des‐octanoyl ghrelin on myocardial injury induced by isoproterenol in rats 1. Acta Pharmacologica Sinica, 27(5), 527-535. Reference40 Li, Z., Xu, G., Qin, Y., Zhang, C., Tang, H., Yin, Y., Zhao, J., Mulholland, M., & Zhang, W. (2014). Ghrelin promotes hepatic lipogenesis by activation of mTOR-PPARγ signaling pathway. Proceedings of the National Academy of Sciences, 111(36), 13163-13168. Reference41 Lien, G.-S., Lin, C.-H., Yang, Y.-L., Wu, M.-S., & Chen, B.-C. (2016). Ghrelin induces colon cancer cell proliferation through the GHS-R, Ras, PI3K, Akt, and mTOR signaling pathways. European journal of pharmacology, 776, 124-131. Reference42 Lin, TC., & Hsiao, M. (2017). Ghrelin and cancer progression. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 1868(1), 51-57. Reference43 Liu, J., Lin, H., Cheng, P., Hu, X., & Lu, H. (2009). Effects of ghrelin on the proliferation and differentiation of 3T3-L1 preadipocytes. Journal of Huazhong University of Science and Technology [Medical Sciences], 29(2), 227-230. 44 ReferenceLongo, KA., Charoenthongtrakul, S., Giuliana, DJ., Govek, EK., McDonagh, T., Qi, Y., DiStefano, PS., & Geddes, BJ. (2008). Improved insulin sensitivity and metabolic flexibility in ghrelin receptor knockout mice. Regulatory peptides, 150(1-3), 55-61. Reference45 Martini, A., Fernandez-Fernandez, R., Tovar, S., Navarro, V., Vigo, E., Vazquez, M., Davies, JS., Thompson, NM., Aguilar, E., Pinilla, L., Wells, T., Dieguenez, C., & TenaSempere, M. (2006). Comparative analysis of the effects of ghrelin and unacylated ghrelin on luteinizing hormone secretion in male rats. Endocrinology, 147(5), 2374-2382. Reference46 Nagaya, N., & Kangawa, K. (2003). Ghrelin, a novel growth hormone-releasing peptide, in the treatment of chronic heart failure. Regulatory peptides, 114(2-3), 71-77. Reference47 Nikolopoulos, D., Theocharis, S., & Kouraklis, G. (2010). Ghrelin: a potential therapeutic target for cancer. Regulatory peptides, 163(1-3), 7-17. Reference48 Nonogaki, K., Nozue, K., & Oka, Y. (2006). Hyperphagia alters expression of hypothalamic 5-HT2C and 5-HT1B receptor genes and plasma des-acyl ghrelin levels in Ay mice. Endocrinology, 147(12), 5893-5900. Reference49 Özcan, B., Neggers, SJ., Miller, AR., Yang, HC., Lucaites, V., Abribat, T., Allas, S., Huisman, M., Visser, JA., Themmen, AP., Sijbrands, EJ., Delhanty, PJ., & van der Lely, AJ. (2014). Does des-acyl ghrelin improve glycemic control in obese diabetic subjects by decreasing acylated ghrelin levels? European Journal of Endocrinology, 170(6), 799-807. Reference50 Pacifico, L., Poggiogalle, E., Costantino, F., Anania, C., Ferraro, F., Chiarelli, F., & Chiesa, C. (2009). Acylated and nonacylated ghrelin levels and their associations with insulin resistance in obese and normal weight children with metabolic syndrome. European Journal of Endocrinology, 161(6), 861-870. Reference51 Rodríguez, A., Gomez-Ambrosi, J., Catalan, V., Becerril, S., Sainz, N., Gil, MJ., Silva, C., Salvador, J., Barba, J., Colina, I., Frushbeck, G. (2010). Association of plasma acylated ghrelin with blood pressure and left ventricular mass in patients with metabolic syndrome. Journal of hypertension, 28(3), 560-567. Reference52 Schmidt, A., Fabrizii, V., Maier, C., Riedl, M., Schmidt, A., Kotzmann, H., Geyer, G., Luger, A. (2004). Normal regulation of elevated plasma ghrelin concentrations in dialysis patients. Wiener Klinische Wochenschrift, 116(7-8), 235-239. Reference53 St-Pierre, D. H., Karelis, A. D., Coderre, L., Malita, F., Fontaine, J., Mignault, D., Brouchu, M., Bastard, JP., Cianflone, K., Doucet, E., Imbeault, P., Rabasa-Lhoret, R. (2007). Association of acylated and nonacylated ghrelin with insulin sensitivity in overweight and obese postmenopausal women. The Journal of Clinical Endocrinology & Metabolism, 92(1), 264-269. Reference54 Thompson, NM., Gill, DA., Davies, R., Loveridge, N., Houston, PA., Robinson, IC., & Wells, T. (2004). Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology, 145(1), 234-242. Reference55 Tolle, V., Bassant, M.-H., Zizzari, P., Poindessous-Jazat, F., Tomasetto, C., Epelbaum, J., & Bluet-Pajot, M.-T. (2002). Ultradian rhythmicity of ghrelin secretion in relation with GH, feeding behavior, and sleep-wake patterns in rats. Endocrinology, 143(4), 1353-1361. Reference56 Vestergaard, E. T., Buhl, M., Gjedsted, J., Madsen, M., Jessen, N., Nielsen, S., Gaylinn, BD., Liu, J., Thırner, MO., Moller, N., & Jorgensen, JO. (2011). Acute peripheral metabolic effects of intraarterial ghrelin infusion in healthy young men. The Journal of Clinical Endocrinology & Metabolism, 96(2), 468-477. Reference57 Vestergaard, ET., Jessen, N., Møller, N., & Jørgensen, JOL. (2017). Acyl ghrelin induces insulin resistance independently of GH, cortisol, and free fatty acids. Scientific reports, 7, 42706. Reference58 Vulliémoz, N. R., Xiao, E., Xia-Zhang, L., Germond, M., Rivier, J., & Ferin, M. (2004). Decrease in luteinizing hormone pulse frequency during a five-hour peripheral ghrelin infusion in the ovariectomized rhesus monkey. The Journal of Clinical Endocrinology & Metabolism, 89(11), 5718-5723. Reference59 Yang, J., Brown, M. S., Liang, G., Grishin, N. V., & Goldstein, J. L. (2008). Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell, 132(3), 387-396. Reference60 Yano, Y., Nakazato, M., Toshinai, K., Inokuchi, T., Matsuda, S., Hidaka, T., Kayakawa,K., Shimada, K., & Kario, K. (2013). Circulating des-acyl ghrelin improves cardiovascular risk prediction in older hypertensive patients. American journal of hypertension, 27(5), 727-733. Reference61 Yoshimoto, A., Mori, K., Sugawara, A., Mukoyama, M., Yahata, K., Suganami, T., Takaya, K., Hosoda, H., Kojima, M., Kangawa, K., & Nakao, K. (2002). Plasma ghrelin and desacyl ghrelin concentrations in renal failure. Journal of the American Society of Nephrology, 13(11), 2748-2752. Reference62 Zhang, G., Yin, X., Qi, Y., Pendyala, L., Chen, J., Hou, D., & Tang, C. (2010). Ghrelin and cardiovascular diseases. Current cardiology reviews, 6(1), 62-70. Reference63 Zhu, X., Cao, Y., Voodg, K., & Steiner, D. F. (2006). On the processing of proghrelin to ghrelin. Journal of Biological Chemistry, 281(50), 38867-38870. Reference64 Zorrilla, E. P., Iwasaki, S., Moss, J. A., Chang, J., Otsuji, J., Inoue, K., Meijler, MM., & Janda, KD. (2006). Vaccination against weight gain. Proceedings of the National Academy of Sciences, 103(35), 13226-13231.